SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551986-19-000042
Filing Date
2019-05-01
Accepted
2019-05-01 16:48:28
Documents
10
Period of Report
2019-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k50119.htm 8-K 44362
2 EXHIBIT 4.1 ex41formofwarrant.htm EX-4.1 106813
3 EXHIBIT 4.2 ex42placementagentwarrant.htm EX-4.2 111151
4 EXHIBIT 5.1 ex51opinion50119.htm EX-5.1 17320
5 EXHIBIT 10.1 ex101securitiespurchaseagr.htm EX-10.1 241230
6 EXHIBIT 10.2 ex102hcwengagementletter.htm EX-10.2 59643
7 EXHIBIT 99.1 ex991pressrelease42919.htm EX-99.1 11391
8 EXHIBIT 99.2 ex992pressrelease5119.htm EX-99.2 11229
9 innt_image1a01.jpg GRAPHIC 17486
10 innt_image1a05.jpg GRAPHIC 11625
  Complete submission text file 0001551986-19-000042.txt   644916
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 19788275
SIC: 2834 Pharmaceutical Preparations